Professional flash glucose monitoring and health service utilisation in type 2 diabetes: A secondary analysis of the GP-OSMOTIC study

Type 2 diabetes mellitus (T2D) affects over one million Australians and costs over $14 billion dollars annually [1]. Most T2D care takes place in primary care where complications, and their associated costs, can be reduced with evidence-based interventions to achieve glycaemic targets [2,3]. Emerging evidence suggests that HbA1c, traditionally used to monitor glycaemia and guide treatment decisions, has limitations as it does not capture parameters such as time in range and glycaemic variability [4], which are increasingly seen as key measures associated with progression to complications [5,6].

Source: Primary Care Diabetes - August 27, 2020 Category: Primary Care Authors: Rita McMorrow, Sharmala Thuraisingam, John Furler, Jo-Anne Manski-Nankervis Tags: Original research Source Type: research